Off-market insider buying at Blueberries Medical (C:BBM)

Facundo Garreton, a Director, acquired 3,832,445 Common Shares on a direct ownership basis at a price of $0.011 through a private transaction on December 29th, 2023. The insider also acquired 145,880,182 Common Shares on an indirect ownership basis for registered holder Terraflos Inc. at a price of $0.011 through a private transaction on December 29th, 2023. This represents a $1,646,839 investment into the company's shares and an account share holdings change of greater than 100%.

Guillermo Pablo Rodriguez, a Senior Officer, acquired 2,967,055 Common Shares on a direct ownership basis at a price of $0.011 through a private transaction on December 29th, 2023. This represents a $32,638 investment into the company's shares and an account share holdings change of greater than 100%.

Blueberries Medical is in the Drug Retailers Sub Industry Group under the Consumer Non-Cyclicals Sector.

Blueberries Medical Corp. is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the growth, cultivation, and development of medicinal cannabis and related products with operations in Colombia. The Company is focused on processing and supplying medicinal-grade Cannabis oil extracts, medical flowers, and related products. It is developing and commercializing a range of cannabis-derived ingredients, including high and low tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. The Company's subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN). Blueberries SAS is a licensed producer and distributor of medicinal Cannabis and Cannabis-derived products in Colombia.